Yacca Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Uttar Pradesh, Uttar Pradesh, India, established in 1989.
1989 Uttar Pradesh, Uttar Pradesh, India Active
Last Updated:
Access Report
About Yacca Pharmaceuticals Private Limited

Yacca Pharmaceuticals Private Limited, a active private limited company, was established on 11 December 1989 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231UP1989PTC011458. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.00 M.

It upholds a compliant status. Employing 31 professional, Its leadership includes Anjali Bansal (Director), Pankaj Kumar Bansal (Managing Director), Aayush Mohan Bansal (Director). It holds ₹49.02 Cr open charges and ₹4.48 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 220/1Hirapur Siyana Road Bulandshahr, Uttar Pradesh, Uttar Pradesh, 203001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231UP1989PTC011458

  • Registration Number

    011458

  • Incorporation Date

    11 December 1989

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 36 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 49.02 Cr
  • Satisfied Charges ₹ 4.48 Cr
  • Revenue Growth **** 13.62%
  • Profit Growth **** 15.09%
  • Ebitda **** 51.81%
  • Net Worth 5.18%
  • Total Assets **** 3.69%
Company report

Yacca Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Yacca Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Yacca Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anjali Bansal Director 11 Dec 1989 Current
Pankaj Kumar Bansal Managing Director 11 Dec 1989 Current
Aayush Mohan Bansal Director 11 Aug 2018 Current
Prateek Mohan Bansal Director 11 Aug 2018 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Yacca Pharmaceuticals.

Yacca Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.62% increase. The company also saw a substantial improvement in profitability, with a 15.09% increase in profit. The company's net worth moved up by a moderate rise of 5.18%.

Yacca Pharmaceuticals revenue growth over time
Yacca Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 13.62%
*******
*******
*******
*******
Revenue from Operations
*******
 13.27%
*******
*******
*******
*******
Total Assets
*******
 3.69%
*******
*******
*******
*******
Profit or Loss
*******
 15.09%
*******
*******
*******
*******
Net Worth
*******
 5.18%
*******
*******
*******
*******
EBITDA
*******
 51.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Yacca Pharmaceuticals?

Unlock access to Yacca Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹490,170,200.00

Satisfied Charges

₹44,755,000.00

Charges Breakdown by Lending Institutions
  • Others : 29.99 Cr
  • Hdfc Bank Limited : 18.93 Cr
  • Pankaj K. Bansal : 0.10 Cr
Latest Charge Details
Date Lender Amount Status
06 Sep 2022 Others ₹29.99 Cr Open
16 Sep 2020 Hdfc Bank Limited ₹18.93 Cr Open
16 May 1994 Pankaj K. Bansal ₹1.00 M Open
27 Nov 2019 Others ₹2.38 Cr Satisfied
02 Jan 2016 Hdfc Bank Limited ₹2.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Yacca Pharmaceuticals?

Yacca Pharmaceuticals has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Yacca Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yacca Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Yacca Pharmaceuticals
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 189.32 M registered on 16 Sep 2020 with Charge ID 100388330 was modified on 06 Jun 2025. was documented.

  • Charges

    Progress on A charge with Others of Rs. 299.85 M registered on 06 Sep 2022 with Charge ID 100612073 was modified on 29 Jan 2025. was documented.

  • Annual General Meeting

    Yacca Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Yacca Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.

  • Charges

    The activity A charge with Others amounted to Rs. 299.85 M with Charge ID 100612073 was registered on 06 Sep 2022. was completed.

  • Charges

    Progress on A charge registered on 27 Nov 2019 via Charge ID 100305438 with Others was fully satisfied on 12 Jan 2021. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Yacca Pharmaceuticals Private Limited?

The CIN of Yacca Pharmaceuticals Private Limited is U24231UP1989PTC011458.

Where is Yacca Pharmaceuticals Private Limited headquartered?

Yacca Pharmaceuticals Private Limited is headquartered at 220/1Hirapur Siyana Road Bulandshahr, Uttar Pradesh, Uttar Pradesh, 203001.

When was Yacca Pharmaceuticals Private Limited incorporated?

Yacca Pharmaceuticals Private Limited was incorporated on 11 December 1989.

Who are the current directors of Yacca Pharmaceuticals Private Limited?

The current directors of Yacca Pharmaceuticals Private Limited are

What is the primary industry of Yacca Pharmaceuticals Private Limited?

The primary industry of Yacca Pharmaceuticals Private Limited is Manufacturing.

Is Yacca Pharmaceuticals Private Limited a listed company?

Yacca Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Yacca Pharmaceuticals Private Limited?

The authorized capital of Yacca Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹1.00 M.

What is the compliance status of Yacca Pharmaceuticals Private Limited?

The compliance status of Yacca Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available